Your browser doesn't support javascript.
loading
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study.
Das, Ankita; Hendershot, Christian S; Husain, M Ishrat; Knyahnytska, Yuliya; Elsaid, Sonja; Le Foll, Bernard; Kloiber, Stefan.
Afiliação
  • Das A; Institute of Medical Sciences, University of Toronto, Toronto, Canada.
  • Hendershot CS; Centre for Addiction and Mental Health, Toronto, Canada.
  • Husain MI; Department of Psychiatry and Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA.
  • Knyahnytska Y; Institute of Medical Sciences, University of Toronto, Toronto, Canada.
  • Elsaid S; Department of Psychiatry, University of Toronto, Toronto, Canada.
  • Le Foll B; Centre for Addiction and Mental Health, Toronto, Canada.
  • Kloiber S; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
Pharmacopsychiatry ; 57(3): 141-151, 2024 May.
Article em En | MEDLINE | ID: mdl-38467156
ABSTRACT

INTRODUCTION:

Perceptions of cannabis as a potential medical treatment for mood and anxiety disorders have been increasing in the context of legalizations, availability, and medical cannabis programs, though current evidence predominately indicates risks and negative effects of cannabis use (CU) on mental health outcomes. This study aims to understand motivations, perceptions, effects, and patterns of CU in individuals with mood and anxiety disorders.

METHODS:

Thirty-six adult patients diagnosed with mood or anxiety disorders, obsessive-compulsive disorder, or posttraumatic stress disorder who were currently using cannabis completed an in-depth qualitative interview on individual motivations, perceptions, experiences, effects, and patterns of their CU. The thematic analysis focused on phases of CU and sources of cannabis products and information.

RESULTS:

Reported motivations for initiation of CU included curiosity, peer pressure, and dissatisfaction with conventional treatments. Factors such as psychotropic effects and coping with mental health symptoms and insomnia contributed to the continuation of CU. More negative effects, including cognitive dysfunction, worsening of mood, and anxiety symptoms, were acknowledged with ongoing CU. Concerning findings included common initiation of CU before age 18, combined medical and recreational CU, rare consultation of medical professionals on CU, and potential effects and harms.

DISCUSSION:

Findings indicate individual complexity of motivations, perceptions, and patterns of CU in the study population. The reported potential beneficial effects of specific cannabis products should be further investigated. Findings emphasize patient-provider dialogue on both CU and conventional treatments. Information from this study can contribute to and inform the development of education, prevention, and intervention strategies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos de Ansiedade / Transtornos do Humor / Pesquisa Qualitativa / Maconha Medicinal Limite: Adult / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos de Ansiedade / Transtornos do Humor / Pesquisa Qualitativa / Maconha Medicinal Limite: Adult / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article